# Allogeneic MSC Treatment for Pulmonary Emphysema

> **NCT04918706** · PHASE2 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Emphysema
- Mesenchymal Stromal Cells

## Interventions

- **GENETIC:** Allogeneic MSC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04918706
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-25
- **Primary completion:** 2021-09-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-06-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918706, "Allogeneic MSC Treatment for Pulmonary Emphysema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04918706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*